Tag Archives: APDN

Hot Heal Care Stocks To Buy Right Now

Shares of Goldstone Infratech locked at 5 percent upper circuit as company has launched its new electric feeder bus eBuzz k6.

The company announced the launch as well as export of its full electric feeder bus eBuzz KG, the 1st bus in this category to be manufactured in India.

With a distinction of being the 1st electric feeder bus in the country, the 18 seater Goldstone-BYD eBuzz KG zero emission electric vehicle has been aesthetically designed to offer utmost comfort to the passengers, company said in release.

Naga Satyam, executive director of Goldstone lnfratech said, “Goldstone-BYD has been spearheading the electric vehicle adoption in the country.”

related news KDDL locked at 5% upper circuit; board to consider fund raising on June 11 Lemon Tree Hotels gains 2% as company licenses property in Gwalior Market Update: Bulls charge ahead as midcaps rally; RIL, JSPL jump 2-4%, Avanti Feeds zooms 12%

“Our focus has not only been to ‘Make in India ‘ but also ‘Made for India’ to meet the requirements of our diversity in the landscapes and terrains of the country,” he added.

Hot Heal Care Stocks To Buy Right Now: Topdanmark A/S (TOP)

Advisors’ Opinion:

  • [By Max Byerly]

    ILLEGAL ACTIVITY NOTICE: “Enertopia (TOP) Stock Price Up 16.7%” was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at www.tickerreport.com/banking-finance/4181611/enertopia-top-stock-price-up-16-7.html.

  • [By Max Byerly]

    TopCoin (CURRENCY:TOP) traded flat against the U.S. dollar during the one day period ending at 7:00 AM E.T. on September 8th. In the last seven days, TopCoin has traded flat against the U.S. dollar. TopCoin has a total market capitalization of $0.00 and $0.00 worth of TopCoin was traded on exchanges in the last day. One TopCoin coin can now be bought for about $0.0008 or 0.00000010 BTC on major cryptocurrency exchanges.

  • [By Logan Wallace]

    TopCoin (CURRENCY:TOP) traded flat against the US dollar during the 24-hour period ending at 16:00 PM E.T. on March 9th. During the last seven days, TopCoin has traded flat against the US dollar. One TopCoin coin can currently be bought for about $0.0008 or 0.00000010 BTC on cryptocurrency exchanges. TopCoin has a market capitalization of $0.00 and $0.00 worth of TopCoin was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    TopCoin (CURRENCY:TOP) traded down 15.4% against the dollar during the 1-day period ending at 7:00 AM E.T. on June 21st. During the last seven days, TopCoin has traded up 4% against the dollar. TopCoin has a market cap of $0.00 and approximately $123.00 worth of TopCoin was traded on exchanges in the last day. One TopCoin coin can currently be bought for about $0.0010 or 0.00000015 BTC on popular exchanges.

Hot Heal Care Stocks To Buy Right Now: Babson Capital Participation Investors(MPV)

Advisors’ Opinion:

  • [By Max Byerly]

    Mountain Province Diamonds Inc (TSE:MPV) (NYSE:MDM) announced a quarterly dividend on Wednesday, August 8th, Zacks reports. Shareholders of record on Monday, September 10th will be paid a dividend of 0.04 per share on Tuesday, September 25th. This represents a $0.16 dividend on an annualized basis and a yield of 4.78%. The ex-dividend date is Friday, September 7th.

Hot Heal Care Stocks To Buy Right Now: Applied DNA Sciences Inc(APDN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media coverage about Applied DNA Sciences (NASDAQ:APDN) has trended somewhat positive on Monday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Applied DNA Sciences earned a daily sentiment score of 0.04 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 47.7961768116482 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

  • [By Stephan Byrd]

    Applied DNA Sciences Inc (NASDAQ:APDN) shares rose 5.3% during mid-day trading on Wednesday . The company traded as high as $1.84 and last traded at $1.60. Approximately 2,707 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 165,954 shares. The stock had previously closed at $1.52.

Hot Heal Care Stocks To Buy Right Now: Seaspan Corporation(SSW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    SEASPAN Corp/SH SH (NYSE:SSW) was downgraded by equities researchers at Wells Fargo & Co from a “market perform” rating to an “underperform” rating in a research report issued on Friday, Marketbeat.com reports. They currently have a $6.00 price objective on the shipping company’s stock. Wells Fargo & Co’s target price would suggest a potential downside of 27.97% from the stock’s current price.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on SEASPAN Corp/SH SH (SSW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribing]

    Seaspan (NYSE:SSW) Q2 2018 Earnings Conference CallAug. 2, 2018 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

  • [By Matthew DiLallo]

    Seaspan (NYSE:SSW) ended 2018 on a high note as it delivered record revenue, operating earnings, and cash flow for the fourth quarter, which pushed its full-year results to record levels as well. Driving that strong showing was the buyout of a joint venture, which significantly increased its fleet. On top of its strong financial results, Seaspan also shored up its balance sheet by closing several transactions with Fairfax Financial (NASDAQOTH:FRFHF), which is now its largest shareholder.

Hot Heal Care Stocks To Buy Right Now: La-Z-Boy Incorporated(LZB)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    If the answer is no, then understand that you are not alone – and you need to click here now…

    Stocks to Watch Today: HSBC, NAVI, LUV
    Shares of HSBC Holdings Plc. (NYSE: HSBC) fell more than 2% in pre-market hours. The slide came after the bank announced that it anticipated “a weaker global economic outlook.” The bank also issued a warning about the upcoming Brexit and said that many of its customers in the United Kingdom are “understandably cautious about the immediate future.” The firm also issued a weaker earnings report than expected. The company to watch today is Navient Corp. (NASDAQ: NAVI), which is the largest student loan servicer in the country. Sallie Mae spun off the company in 2013. It has 12 million customers and services about $300 billion in loans. While no one likes student loans, a few key metrics show this stock is a raging buy right now. Here’s what you need to know to get your trading week started. Southwest Airlines Co. (NYSE: LUV) is under scrutiny from the Federal Aviation Administration. According to reports, a probe is underway on whether the company has failed to calculate checked baggage loads on flights correctly. The Wall Street Journal reports that several planes carried 1,000 pounds of cargo more than what was listed on flight paperwork. Look for earnings reports from Advance Auto Parts Inc. (NYSE: AAP), Ecolab Inc. (NYSE: ECL), La-Z-Boy Inc. (NYSE: LZB), LendingClub Corp. (NYSE: LC), and Texas Roadhouse Inc. (NASDAQ: TXRH).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Steve Symington]

    Shares of La-Z-Boy Incorporated (NYSE:LZB) were up 12.6% as of 1:30 p.m. EDT on Wednesday after the furniture producer announced strong fiscal first-quarter 2019 results.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on La-Z-Boy (LZB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Dan Caplinger]

    Thursday was another relatively calm day on Wall Street, with most major benchmarks easing very slightly lower. Fears about Washington scandals and trade tensions between the U.S. and China weighed on enthusiasm over a strong U.S. economy as economists and policymakers met in Jackson Hole, Wyoming, for the Federal Reserve’s annual symposium to discuss economic prospects across the globe. At a more granular level, some companies suffered from downbeat news that sent their share prices lower. IAMGOLD (NYSE:IAG), Hertz Global Holdings (NYSE:HTZ), and La-Z-Boy (NYSE:LZB) were among the worst performers on the day. Here’s why they did so poorly.

Hot Heal Care Stocks To Buy Right Now: Ascendis Pharma A/S(ASND)

Advisors’ Opinion:

  • [By Chris Lange]

    Ascendis Pharma A/S (NASDAQ: ASND) is expected to present full Phase 1 data from its TransCon-PTH hypoparathyroidism treatment later this month. Shares of Ascendis closed Friday at $66.78, with a consensus analyst target of $80.17 and a 52-week range of $22.25 to $76.29.

  • [By Dan Caplinger]

    The stock market lost ground on Monday, as investors appeared to have second thoughts about the future of the U.S. economy even as trade negotiations with China appear to be going well. The Dow Jones Industrial Average had been down by more than 400 points earlier in the session before recovering to finish lower by just 207, and broader benchmarks saw more modest declines on a percentage basis. Even amid the carnage, there was some good news for certain companies. Washington Real Estate Investment Trust (NYSE:WRE), Ascendis Pharma (NASDAQ:ASND), and Bluegreen Vacations (NYSE:BXG) were among the top performers. Here’s why they did so well.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ascendis Pharma A/S (ASND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    BidaskClub lowered shares of Ascendis Pharma A/S (NASDAQ:ASND) from a hold rating to a sell rating in a research report report published on Wednesday morning.

  • [By Cory Renauer]

    Shares of Ascendis Pharma (NASDAQ:ASND), a biopharmaceutical company committed to extended-release technology, are soaring after the company released pivotal trial results for its lead candidate. Investors expecting blockbuster sales have pushed the stock 58.8% higher as of 12:04 p.m. EST on Monday. 

Hot Low Price Stocks To Own Right Now

Source: ThinkstockUntil about 2008 or so, discussion about the future price of crude oil was directed by the concept of peak oil. That is, when does the world reach peak production, after which the price of crude will skyrocket. In less than a decade, the discussion is now focused on the concept of “peak demand,” the point at which global demand for crude begins to decline.

The recent Oil & Money conference in London sharpened the focus on peak demand. Saudi Arabia’s minister of energy and industry, Khalid Al-Falih, told conference attendees that cutbacks in capital spending on exploration, forced on the industry by low prices for the past two years, could mean that shortfalls in supply are coming.

Exxon Mobil Corp. (NYSE: XOM) CEO Rex Tillerson disagreed:

Hot Low Price Stocks To Own Right Now: Aceto Corporation(ACET)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Aceto (NASDAQ: ACET) and PetIQ (NASDAQ:PETQ) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends and profitability.

  • [By Shane Hupp]

    Aceto (NASDAQ: ACET) and PetIQ (NASDAQ:PETQ) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership.

  • [By Chris Lange]

    Aceto Corp. (NASDAQ: ACET) saw its shares halved on Thursday after the company gave a critical update. There is a lot going on for Aceto in this update, and most of it is not good news. Amid credit negotiations there are also changes at the highest level of management, making this a tough pill to swallow.

  • [By Stephan Byrd]

    Aceto (NASDAQ:ACET) will be posting its quarterly earnings results after the market closes on Wednesday, September 12th. Analysts expect Aceto to post earnings of $0.26 per share for the quarter.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

  • [By Lisa Levin]

    Aceto Corporation (NYSE: ACET) shares dropped 62 percent to $2.795 following announcement of financial challenges. The company has suspended further guidance and is evaluating strategic alternatives. Aceto also expects reduction in dividend moving forward. Canaccord Genuity downgraded Aceto from Buy to Sell.

Hot Low Price Stocks To Own Right Now: Capital Senior Living Corporation(CSU)

Advisors’ Opinion:

  • [By Logan Wallace]

    Barclays reissued their average rating on shares of Capital Senior Living (NYSE:CSU) in a research note released on Monday morning.

    Several other equities analysts have also issued reports on the company. ValuEngine lowered Capital Senior Living from a strong-buy rating to a buy rating in a research note on Thursday, December 27th. JMP Securities restated an outperform rating on shares of Capital Senior Living in a research note on Monday, December 31st. Finally, Zacks Investment Research upgraded Capital Senior Living from a hold rating to a buy rating and set a $8.75 price target on the stock in a research note on Monday, January 21st. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Capital Senior Living presently has a consensus rating of Hold and an average price target of $9.38.

  • [By Max Byerly]

    State of New Jersey Common Pension Fund D lessened its stake in shares of Capital Senior Living (NYSE:CSU) by 5.3% in the first quarter, Holdings Channel reports. The institutional investor owned 180,000 shares of the company’s stock after selling 10,000 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Capital Senior Living were worth $1,935,000 as of its most recent filing with the SEC.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Capital Senior Living (CSU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Media stories about Capital Senior Living (NYSE:CSU) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Capital Senior Living earned a daily sentiment score of 0.01 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.062391046142 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Hot Low Price Stocks To Own Right Now: Applied DNA Sciences Inc(APDN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media coverage about Applied DNA Sciences (NASDAQ:APDN) has trended somewhat positive on Monday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Applied DNA Sciences earned a daily sentiment score of 0.04 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 47.7961768116482 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Stephan Byrd]

    Applied DNA Sciences Inc (NASDAQ:APDN) shares rose 5.3% during mid-day trading on Wednesday . The company traded as high as $1.84 and last traded at $1.60. Approximately 2,707 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 165,954 shares. The stock had previously closed at $1.52.

  • [By Shane Hupp]

    Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Hot Low Price Stocks To Own Right Now: Morgan Stanley Asia-Pacific Fund, Inc.(APF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Peel Hunt upgraded shares of Anglo Pacific Group (LON:APF) to a buy rating in a report released on Tuesday morning. Peel Hunt currently has GBX 190 ($2.53) target price on the stock, up from their previous target price of GBX 181 ($2.41).

Hot Canadian Stocks To Watch For 2019

President-elect Donald Trump has achieved a Twitter milestone: 20 million followers.

Trump has been climbing the Twitter charts recently, thanks in part to his frequent use of the social networking site. Sometime on Monday he surpassed the 20 million mark.

According to the measuring tool TwitterCounter, Trump is the 68th-most-followed user on the site, just behind Canadian singer Avril Lavigne and right ahead of Indian actor Aamir Khan.

Trump’s aides had been keeping a close eye on the follower number, waiting for the account to reach 20 million.

The president-elect brings up his social media stats on a regular basis, adding up the users who follow him on Twitter, Facebook and Instagram to say he reaches 46 million people through the three sites.

The total, while impressive, is belied by the fact, like many social media users, Trump has some followers that are either robots (known as “bots”) or dormant users who never see what he posts.

Hot Canadian Stocks To Watch For 2019: Glacier Bancorp, Inc.(GBCI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Glacier Bancorp, Inc. (NASDAQ:GBCI) has been assigned an average recommendation of “Hold” from the eight research firms that are currently covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $43.50.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Glacier Bancorp (GBCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Glacier Bancorp, Inc. (NASDAQ:GBCI)’s share price hit a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $41.40 and last traded at $41.05, with a volume of 6787 shares changing hands. The stock had previously closed at $41.15.

  • [By Joseph Griffin]

    Swiss National Bank lifted its position in Glacier Bancorp (NASDAQ:GBCI) by 2.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 135,800 shares of the bank’s stock after acquiring an additional 2,900 shares during the period. Swiss National Bank owned about 0.16% of Glacier Bancorp worth $5,212,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Glacier Bancorp (GBCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Canadian Stocks To Watch For 2019: Applied DNA Sciences Inc(APDN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

  • [By Stephan Byrd]

    Applied DNA Sciences Inc (NASDAQ:APDN) shares rose 5.3% during mid-day trading on Wednesday . The company traded as high as $1.84 and last traded at $1.60. Approximately 2,707 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 165,954 shares. The stock had previously closed at $1.52.

  • [By Ethan Ryder]

    NV5 Global (NASDAQ: NVEE) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends.

  • [By Logan Wallace]

    NV5 Global (NASDAQ: NVEE) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

  • [By Logan Wallace]

    Media coverage about Applied DNA Sciences (NASDAQ:APDN) has trended somewhat positive on Monday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Applied DNA Sciences earned a daily sentiment score of 0.04 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 47.7961768116482 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Max Byerly]

    These are some of the media headlines that may have effected Accern Sentiment’s rankings:

    Get Applied DNA Sciences alerts:

    Applied DNA Sciences’ (APDN) CEO James Hayward on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com) Edited Transcript of APDN earnings conference call or presentation 3-May-18 8:30pm GMT (finance.yahoo.com) Applied DNA Sciences: Fiscal 2Q Earnings Snapshot (finance.yahoo.com) Applied DNA Sciences (APDN) Stock Rating Upgraded by ValuEngine (americanbankingnews.com) Applied DNA Reports Fiscal Second Quarter 2018 Financial Results (finance.yahoo.com)

    A number of research analysts have issued reports on the stock. Maxim Group set a $5.00 price target on shares of Applied DNA Sciences and gave the stock a “buy” rating in a report on Friday, April 6th. ValuEngine raised shares of Applied DNA Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.

Hot Canadian Stocks To Watch For 2019: Poage Bankshares, Inc.(PBSK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Poage Bankshares (NASDAQ:PBSK) announced its earnings results on Monday. The savings and loans company reported $0.21 earnings per share (EPS) for the quarter, Bloomberg Earnings reports. The company had revenue of $5.39 million for the quarter. Poage Bankshares had a negative return on equity of 4.84% and a negative net margin of 14.32%.

  • [By Joseph Griffin]

    News coverage about Poage Bankshares (NASDAQ:PBSK) has been trending somewhat negative on Thursday, according to Accern. The research firm identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Poage Bankshares earned a daily sentiment score of -0.06 on Accern’s scale. Accern also assigned headlines about the savings and loans company an impact score of 47.5091086029881 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Top Medical Stocks To Watch Right Now

BioXel Therapeutics has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details weregiven in the filing, but the offering is valued up to $69.0 million. The company intends to list its shares on the Nasdaq under the symbol BTAI.

The underwriters for the offering are Barclays, UBS Investment Bank and BMO Capital Markets.

This is a clinical-stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.

The firms drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices.

Management believes that this differentiated approach has the potential to reduce the cost and time of drug development in diseases with substantial unmet medical need.

Top Medical Stocks To Watch Right Now: Plains Group Holdings, L.P.(PAGP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    TheStreet upgraded shares of Plains GP (NYSE:PAGP) from a d+ rating to a c- rating in a research report released on Monday morning.

    Several other analysts have also recently issued reports on the company. Stifel Nicolaus cut Plains GP from a buy rating to a hold rating and set a $24.00 price objective on the stock. in a report on Wednesday. Jefferies Group cut Plains GP from a buy rating to a hold rating in a report on Wednesday, April 25th. Wolfe Research cut Plains GP from a market perform rating to an underperform rating in a report on Tuesday, April 24th. Deutsche Bank began coverage on Plains GP in a report on Thursday, April 19th. They set a buy rating and a $29.00 price objective on the stock. Finally, SunTrust Banks raised Plains GP from a hold rating to a buy rating and set a $27.00 price objective on the stock in a report on Monday, April 9th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $25.65.

  • [By Joseph Griffin]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Plains GP alerts:

    Plains GP (PAGP) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPS (americanbankingnews.com) Plains GP (PAGP) Upgraded by TheStreet to C- (americanbankingnews.com) Plains GP (PAGP) Downgraded by Stifel Nicolaus (americanbankingnews.com) Plains GP Holdings (PAGP) Tops Q1 EPS by 5c, Beats on Revenues (streetinsider.com) Plains All American Pipeline, L.P. and Plains GP Holdings Report First-Quarter 2018 Results (finance.yahoo.com)

    Several research firms have commented on PAGP. TheStreet upgraded shares of Plains GP from a “d+” rating to a “c-” rating in a research report on Monday. Stifel Nicolaus cut shares of Plains GP from a “buy” rating to a “hold” rating and set a $24.00 target price for the company. in a research report on Wednesday. Jefferies Group cut shares of Plains GP from a “buy” rating to a “hold” rating in a research report on Wednesday, April 25th. Wolfe Research cut shares of Plains GP from a “market perform” rating to an “underperform” rating in a research report on Tuesday, April 24th. Finally, Deutsche Bank began coverage on shares of Plains GP in a research report on Thursday, April 19th. They issued a “buy” rating and a $29.00 target price for the company. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $25.65.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

Top Medical Stocks To Watch Right Now: Yum! Brands, Inc.(YUM)

Advisors’ Opinion:

  • [By ]

    For example, when Kentucky Fried Chicken changed its name to KFC (NYSE: YUM), it did so to get the word “fried” out of its advertising in an age of health-conscious customers. Cigarette maker Phillip Morris did the same when they rebranded to Altria (NYSE: MO) in 2003. The political pressures associated with “big tobacco” created a need for a less caustic moniker.

  • [By ]

    Among McDonald’s main rivals, identified by FactSet, are Starbucks Corp. (SBUX) , down almost 5.5%; Yum! Brands (YUM) , which owns KFC, Pizza Hut and Taco Bell, up 32%; and burger chain Sonic Corp. (SONC) , down about 2%. These are all year-over-year percentages.

  • [By ]

    These figures should be a relief for Niccol, who joined the company from Yum! Brands’ (YUM) Taco Bell in February. While he was largely welcomed by investors and received industry affirmation, some critics were skeptical of his franchising background, operational savvy and the disparity in ethos between Chipotle and Taco Bell.

Top Medical Stocks To Watch Right Now: Xilinx, Inc.(XLNX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Daiwa Securities Group Inc. raised its holdings in shares of Xilinx (NASDAQ:XLNX) by 1.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 126,150 shares of the programmable devices maker’s stock after purchasing an additional 2,349 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Xilinx were worth $9,113,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Headlines about Xilinx (NASDAQ:XLNX) have trended somewhat positive this week, according to Accern. The research group identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Xilinx earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned media stories about the programmable devices maker an impact score of 47.7615347434404 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By ]

    Xilinx (XLNX) : “I think it’s time to start getting back into NVIDIA (NVDA) .”

    Celgene (CELG) : “I’d rather buy Amgen (AMGN) or Regeneron Pharmaceuticals (REGN) . I think Celgene overpaid for that acquisition a few years ago.”

  • [By ]

    Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Friday was Xilinx, Inc. (NASDAQ: XLNX) which rose about 5% to $74.15. The stocks 52-week range is $54.99 to $75.14. Volume was 5.6 million compared to its average volume of 2 million.

  • [By ]

    Until it’s lifted, the ban stands to impact everyone from optical component/module suppliers such as Acacia Communications (ACIA)  and Oclaro to telecom/networking chip suppliers such as Cavium (CAVM)  and Xilinx (XLNX) to mobile chip suppliers such as Qualcomm (QCOM)  and Skyworks (SWKS) . Some of the damage will, of course, be offset by share losses ZTE is likely to see on account of the ban. This could particularly hold for mobile suppliers, given that the ban could prevent ZTE from shipping phones running Alphabet/Google’s (GOOGL) version of Android.

Top Medical Stocks To Watch Right Now: Signet Jewelers Limited(SIG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Signal Token (CURRENCY:SIG) traded 33% higher against the U.S. dollar during the twenty-four hour period ending at 23:00 PM ET on May 12th. During the last seven days, Signal Token has traded 136.8% higher against the U.S. dollar. Signal Token has a market capitalization of $9.93 million and approximately $156,257.00 worth of Signal Token was traded on exchanges in the last 24 hours. One Signal Token token can currently be bought for $0.0450 or 0.00000466 BTC on popular exchanges including HitBTC, EtherDelta (ForkDelta), IDEX and Bancor Network.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Signet Jewelers Limited (NYSE: SIG) which traded down about 7% at $52.74. The stocks 52-week range is $46.09 to $86.35. Volume was 8.5 million, well above the daily average of 2.4 million shares.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Signet Jewelers Limited (NYSE: SIG) which traded down about 20% at $38.14. The stocks 52-week range is $38.11 to $77.94. Volume was 25.5 million compared to the daily average volume of 2.1 million.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Signet Jewelers Limited (NYSE: SIG) which rose about 2% to $39.48. The stocks 52-week range is $187.96 to $314.86. Volume was 3.8 million compared to the daily average volume of 2.8 million.

Top Medical Stocks To Watch Right Now: MobileIron, Inc.(MOBL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on MobileIron (MOBL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Watch Right Now: Applied DNA Sciences Inc(APDN)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the media headlines that may have effected Accern Sentiment’s rankings:

    Get Applied DNA Sciences alerts:

    Applied DNA Sciences’ (APDN) CEO James Hayward on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com) Edited Transcript of APDN earnings conference call or presentation 3-May-18 8:30pm GMT (finance.yahoo.com) Applied DNA Sciences: Fiscal 2Q Earnings Snapshot (finance.yahoo.com) Applied DNA Sciences (APDN) Stock Rating Upgraded by ValuEngine (americanbankingnews.com) Applied DNA Reports Fiscal Second Quarter 2018 Financial Results (finance.yahoo.com)

    A number of research analysts have issued reports on the stock. Maxim Group set a $5.00 price target on shares of Applied DNA Sciences and gave the stock a “buy” rating in a report on Friday, April 6th. ValuEngine raised shares of Applied DNA Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.

  • [By Shane Hupp]

    Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.